CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Decisions Regarding Treatments for the Secondary Prevention of Heart Disease: Patient Experiences

Last updated: October 31, 2018
Project Number: RA0981-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the evidence regarding how patients experience, engage with, and make decisions around, treatments for the secondary prevention of heart disease?

Key Message

Two evidence syntheses and eight primary studies were identified that report on how patients experience, engage with and make decisions around treatments for the secondary prevention of heart disease.